SCHEMBL13628674

SCHEMBL13628674

CC(C)NOCCNc1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.51
CYP1A2 P05177 1/20 0.49
CXCR4 P61073 1/20 0.45
ITGB3 P05106 2/20 0.44
ITGAV P06756 2/20 0.44
ITGB1 P05556 1/20 0.44
ITGB5 P18084 1/20 0.44
ITGB6 P18564 1/20 0.44
FABP1 P07148 1/20 0.44
FABP6 P51161 1/20 0.44
CYP2D6 P10635 1/20 0.42
FDPS P14324 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PCSK9 Q8NBP7 1/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
ALOX12 P18054 1/20 0.40
POLB P06746 1/20 0.40
HTR7 P34969 1/20 0.40
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13628532 0.82 CYP2C19 (0.56) CYP2C19CYP1A2CXCR4ITGB3ITGAV
SCHEMBL3647775 0.78 POLB (0.60) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL29980727 0.78 POLB (0.60) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL24485296 0.77 CYP2C19 (0.57) CYP2C19CYP1A2CXCR4ITGB3ITGAV
SCHEMBL3265804 0.75 CYP1A2 (0.70) CYP2C19CYP1A2CXCR4FABP1FABP6
SCHEMBL317566 0.75 ALDH1A1 (0.60) CYP2C19CYP1A2CXCR4ITGB3ITGAV
SCHEMBL18233631 0.74 CYP2C19 (0.54) CYP2C19CYP1A2CXCR4ITGB3ITGAV
SCHEMBL13365309 0.74 CYP2C19 (0.50) CYP2C19CYP1A2CXCR4ITGB3ITGAV
SCHEMBL28657675 0.72 CYP2C19 (0.56) CYP2C19CYP1A2CXCR4ITGB3ITGAV
SCHEMBL7442415 0.72 CYP2C19 (0.56) CYP2C19CYP1A2CXCR4ITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612197-B2 Reacting a nucleophil with OH group with an electrophil to form an adduct, reacting adduct with a reagent selected from oxidizing, sulfurizing or selenizing agents to produce hydroxy protected oligonucleotide, heating to deprotect hydroxy protecting group such as 2-(2-pyridyl)aminoethoxycarbonyl The United States of America as repesented by the Secretary of the Department of Health and Human Services (US) 2009-11-03 US disclosed